Haim Hammerman, MD

Original Contribution

Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Eptifibatide and Abciximab: Outcomes, Complications and Thrombocyto

08/01/2008

Rafael Beyar , MD, DSc, MPH;

Ehud Grenadier , MD;

Walter Markiewicz , MD;

Haim Hammerman , MD;

Monther Boulus , MD;

Alexander Goldberg , MD;

Luis Gruberg , MD;

Doron Aronson , MD;

Mahmoud Suleiman , MD;

Majdi Halabi , MD;

The development of platelet glycoprotein (GP) IIb/IIIa receptor inhibitors has been a major advance in reducing ischemic complications among a broad spectrum of patients undergoing percutaneous coronary intervention (PCI).1–9 Currently, three...

The development of platelet...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Incidence, Predictors and Outcome of Drug-Eluting Stent Thrombosis in Real-World Practice

10/06/2010

Miry Blich , MD;

Tawfiq Zeidan-Shwiri , MD;

Azriel Osherov , MD;

Sirouch Petcherski , MD;

Haim Hammerman , MD;

ABSTRACT: Background. Traditionally, stent thrombosis (STH) has been regarded as a complication of percutaneous coronary interventions during the first 30 post-procedural days. However, delayed endothelialization associated with the...

ABSTRACT: Background....

10/06/2010

Journal of Invasive Cardiology

Original Contribution

Troponin-Positive, CK-MB-Negative Acute Myocardial Infarction:Clinical, Electrocardiographic and Angiographic Characteristics

08/01/2008

Luis Gruberg , MD;

Michael Kapeliovich , MD;

Doron Sudarsky , MD;

Arthur Kerner , MD;

Haim Hammerman , MD;

Rafael Beyar , MD, DSc, MPH;

The recent introduction of cardiac troponin I (cTn-I) into daily routine practice allows for highly accurate, sensitive and specific determination of myocardial injury in patients with chest pain. Any increase in these markers implies...

The recent introduction of...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Glycoprotein IIb/IIIa Inhibitors during Rescue Percutaneous Coronary Intervention in Acute Myocardial Infarction

08/01/2008

Michael Kapeliovich , MD;

Shlomo Amikam , MD;

Walter Markiewicz , MD;

Haim Hammerman , MD;

Mahmoud Sileiman , MD;

Monther Boulus , MD;

Rafael Beyar , MD, DSc, MPH;

Luis Gruberg , MD;

Ehud Grenadier , MD;

Fibrinolytic therapy for acute myocardial infarction, even with the most efficient regimens available, is fraught with a substantial proportion of failures to re-establish normal blood flow in the occluded vessel.1,2 Failure to achieve prompt...

Fibrinolytic therapy for acute...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

The Impact of GP IIb/IIIa Inhibitors During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction Patients

08/01/2008

Ehud Grenadier , MD;

Michael Kapeliovich , MD;

Monther Boulos , MD;

Walter Markiewicz , MD;

Haim Hammerman , MD;

Shahar Lavi , MD, PhD;

Doron Aronson , MD;

Luis Gruberg , MD;

Rafael Beyar , MD, DSc, MPH;

In the last decade, primary percutaneous coronary intervention (PCI) has emerged as a superior strategy compared to thrombolytic therapy for coronary reperfusion in acute myocardial infarction patients.1–4 It is associated with lower...

In the last decade, primary...

08/01/2008

Journal of Invasive Cardiology